Climb Bio, Inc. (CLYM) vs Silence Therapeutics PLC Sponsored ADR (SLN)

Climb Bio, Inc. and Silence Therapeutics PLC Sponsored ADR are both Biotechnology companies. Climb Bio, Inc. and Silence Therapeutics PLC Sponsored ADR are of similar size ($697.3M and $682.9M). Across the 9 metrics below, Climb Bio, Inc. leads on 7 and Silence Therapeutics PLC Sponsored ADR on 2.

Valuation

Metric CLYM SLN Biotechnology median
P/E n/m n/m 7.88
P/S n/m 629.45 11.47
P/B 3.71 13.73 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 543.65 10.73
Earnings yield (7.12%) (11.45%) (28.84%)
Free cash flow yield (5.99%) (8.01%) (23.03%)

Profitability

Metric CLYM SLN Biotechnology median
Gross margin — 79.50% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (27.10%) (90.41%) (57.72%)
Return on assets (26.27%) (44.14%) (49.22%)
Return on invested capital (71.73%) 0.00% 0.00%

Growth

Metric CLYM SLN Biotechnology median
Revenue growth (TTM) — (96.97%) 5.64%
EPS growth (last fiscal year) 42.48% (90.91%) —
Revenue growth, 5-year CAGR — (39.74%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLYM SLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 31.45 7.42 4.73
Net debt to EBITDA 1.44 0.94 0.96

Dividend

Metric CLYM SLN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CLYM SLN Biotechnology median
Market cap 682.92m 697.32m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack